![A dolorimeter can be used to gauge pain in fibromyalgia patients.](https://www.uc.edu/news/articles/legacy/healthnews/2008/07/h7195/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1534517878801.jpg)
UC HEALTH LINE: New Treatments, Continued Research Offer Hope to Fibromyalgia Sufferers
CINCINNATI
Fibromyalgia is a painful and often debilitating condition that can have a substantial negative impact on quality of life.
Often misdiagnosed or mistaken for lupus, multiple sclerosis or rheumatoid arthritis, fibromyalgiaa chronic, widespread pain conditionaffects more women than men and can lead to stiffness, sleep disruption, fatigue, memory or concentration problems, mood disturbances and even irritable bowel symptoms.
For years, physicians and researchers have worked to better understand fibromyalgia and provide treatments to patients with this condition.
Lesley Arnold, MD, director of the University of Cincinnati (UC) Womens Health Research Program, says that fibromyalgia sufferers now have more treatment options than ever before.
Arnold has led numerous studies on fibromyalgia and was the principal investigator for Cincinnati-based studies of the two medications now approved by the Food and Drug Administration (FDA) for the treatment of fibromyalgiaCymbalta, manufactured by Eli Lilly and approved in June 2008, and Lyrica, manufactured by Pfizer and approved in 2007.
She says that these new treatment options are a step in the right direction, but that more research is needed to find additional approaches for managing the condition.
No two patients are exactly the same, says Arnold, which means that not everyone will respond the same way to currently available treatments."
While it is very gratifying to see that the clinical trials in fibromyalgia have led to the availability of two new treatment options, we need to continue to find alternative approaches to the management of this often disabling disorder, she adds.
The Womens Health Research Program develops personalized treatment plans for fibromyalgia patients and offers access to cutting-edge research studies testing a variety of medications for the condition. They also collaborate with rheumatologists, sleep specialists, neurologists, psychiatrists and physical therapists to determine the best ways for treating patients.
Fibromyalgia studies are being conducted on an ongoing basis. If you are over 18, have been diagnosed with fibromyalgia or suspect you may have the condition and wish to participate in a clinical study, call the Womens Health Research Program at (513) 475-8114.
Arnold is a paid consultant for both Pfizer and Eli Lilly and has received funding from both in support of research studies.
Tags
Related Stories
UC 1819 Innovation Hub partner takes health care from Cincinnati...
August 30, 2024
Christopher Lewis, founder of the Village Life Outreach Project and a professor of medicine at the University of Cincinnati, strives to boost health outcomes in his hometown and across the world in Tanzania.
How to fend off mosquitoes
![The New York Times logo](/content/dam/refresh/uc-news/news-icons/dark/nyt.png)
August 30, 2024
Mosquitoes can transmit pathogens that cause diseases, including West Nile virus and, in very rare cases, a disease known as Eastern equine encephalitis, or E.E.E. A UC expert spoke to the New York Times about simple precautions to keep mosquitoes away.
Study combines data, molecular simulations to accelerate drug...
August 30, 2024
Researchers from the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital have found a new method to increase both speed and success rates in drug discovery. The study, published Aug. 30 in the journal Science Advances, offers renewed promise when it comes to discovering new drugs.